TSPO and central nervous system cancer: Costa and colleagues used the synthetic compound irDE-MPIGA that is designed to bind TSPO covalently and permanently at nanomolar doses, alongside the reversible TSPO ligand PIGA to investigate the effects of stable and transient residence time in the human glioma cell line U87MG cells.